Skip to main content
Clinical Trials/NCT04434820
NCT04434820CompletedNot Applicable

External Negative Pressure Dressing System (ENPDS) vs. Traditional Wound Dressing for Cesarean Section Incision in Obese Women.

Ain Shams Maternity Hospital1 site in 1 country260 target enrollmentStarted: August 3, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
260
Locations
1
Primary Endpoint
incidence of wound dehiscence

Study Overview

Brief Summary

Obesity is associated with increased cesarean section delivery rates and surgical site infections with associated increased post-operative morbidity, post-operative pain and length of hospital stay.

Negative pressure wound therapy (NPWT) technology could be used as a prophylactic measure to reduce surgical site infections in obese women undergoing cesarean section by immediate postoperative application in clean-contaminated, closed surgical incisions.

Detailed Description

Obesity, defined as body mass index (BMI, calculated as weight (kg)/ [height (m)] 2) of 30 or greater, is a common medical comorbidity of pregnancy affecting one third of reproductive-aged women. Maternal obesity is also a well-recognized risk factor for dysfunctional labor and cesarean delivery with a cesarean section rate of 33% in obese women with BMI of 30 or greater and 43% in women with BMIs of 40 or greater.

Obesity is an independent risk factor for post-operative surgical site infection. The risk of post-cesarean surgical site infection has been shown to double for every 5 unit increase in body mass index (BMI) above 30 kg/m , occurring in about 10% of obese women undergoing caesarean section despite prophylactic strategies (e.g. antibiotics).

This can be explained partly by a decreased blood flow in adipose tissue and an obesity-associated inflammation causing vascular dysfunction, which results in a local hypoxic response. Hypoxia impairs oxidative bacterial killing and leads to an increased risk of surgical site infection.

Wound healing is a sequence of physiologic events that include inflammation, epithelialization, fibroplasia, and maturation. Failure of wound healing at the surgical site can lead to seroma, hematoma, wound dehiscence, incisional hernia and surgical site infection.

Surgical site infection SSI according to The Centers for Disease Control and Prevention is as an infection occurring within 30 days from the operative procedure in the part of the body where the surgery took place, where there is purulent drainage from incision, isolated organisms from the incision, dehiscence or deliberate opening by the surgeon when the patient has at least one sign or symptom of clinical infection: localized pain, edema, erythema, warmth and fever greater than 38 c (unless culture of incision is negative) or there is an abscess or other evidence of infection is found during examination of incision, reoperation, or pathologic or radiologic exam.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age: 18 or older
  • •BMI: 30 or greater
  • •undergoing Cesarean section through a Pfannenstiel incision

Exclusion Criteria

  • •Prolonged Rupture of membranes >18 hours
  • •Intra amniotic infection
  • •Severe anemia
  • •Vasculopathies as in hypertension/pre-eclampsia, pregestational / gestational diabetes mellitus, smoking and substance abuse
  • •Prolonged steroids therapy as in SLE, ITP
  • •Intraoperative complications as bladder or bowel injury , placenta previa / accreta, difficult fetal extraction , ovarian cysts, pelvic abscess
  • •Intra-abdominal or subcutaneous drain

Arms & Interventions

standard dressing group

No Intervention

patients will receive sterile wound dressing of gauze and tape for 4 days.

External negative pressure dressing system group

Active Comparator

patients will receive placement of a sterile dressing of gauze and occlusive adhesive over the closed incision. The dressing's tubing will then be attached to a compact, portable negative-pressure therapy unit (Yuwell 7E-A portable suction unit) that will deliver -80 mm Hg of continuous pressure to the dressing and will remove exudates into a disposable canister for 4 days.

Intervention: External negative pressure dressing system (Yuwell 7E-A portable suction unit) (Device)

Outcomes

Primary Outcomes

incidence of wound dehiscence

Time Frame: till 30 days post operative

separation of the incision line prior to complete healing resulting in an open wound.

Secondary Outcomes

  • patient mobility(4 days)
  • surgical site infection(30 days post operative)
  • post operative pain(till 30 days post operative)
  • further need for additional antibiotics(till 30 days post operative)
  • length of hospital stay(till 30 days post operative)
  • the need for re-admission(till 30 days post operative)
  • peri-incision blistering(till 30 days post operative)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dalia Magdy Mokhtar

resident of obstetrics and gynecology

Ain Shams Maternity Hospital

Study Sites (1)

Loading locations...

Similar Trials